Peer review process
Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors.
Read more about eLife’s peer review process.Editors
- Reviewing EditorSameh AliChildren's Cancer Hospital Egypt, Cairo, Egypt
- Senior EditorVolker DötschGoethe University Frankfurt, Frankfurt am Main, Germany
Reviewer #1 (Public Review):
Summary:
Honzejkova K., et al. resolved the structure of one of the MAP3K proteins. Apoptosis signal-regulating kinase 1 (ASK1) is one of the main crucial stress sensors, which directs cells toward differentiation, and apoptosis. As a result, ASK1 dysregulation has been associated with a multitude of diseases like neurodegenerative, cardiovascular, and cancer. Understanding the structural-functional interplay of ASK1 would help researchers target this member of the MAP3K proteins to develop therapeutic interventions for these disorders.
Strengths:
Major strengths:
• Structure of the C-terminal truncated ASK1 protein.
Weaknesses:
• Lack of ASK1:TRX1 complex structure. The authors used instead SV AUC and HDX-MS techniques to compensate for the inability to get a sufficiently stable ASK1:TRX complex.
• There is not enough information about Cryo-EM data processing like 2D classification averages, local resolution of the EM map, or FSC figures.
• You can't reliably report the presence of a hydrogen bond with a 3.7Å resolution.
Reviewer #2 (Public Review):
Summary:
The authors attempted to solve the 3D structure of ASK1 by Cryo-EM.
Strengths:
The authors solved the 3D structure of N-terminal domain s of ASK1 complexed with TRX. They found TRX1 functions as a negative allosteric effector of ASK1, modifying the structure of the TRX1-binding domain and changing its interaction with the tetratricopeptide repeats domain. The conclusions drawn from this paper are convincing and will greatly contribute to the development of new drugs targeting ASK1.
Weaknesses:
To study the ASK1 structure, C-terminally truncated ASK1 was used in the study, but not the full-length form of ASK1.